Skip to main content

Table 1 Major clinicopathologic characteristics of the 100 PC patients

From: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies

Items Value, n (%)
Gender
 Male/female 41 (41)/59 (59)
Age (years)
 <60/≥60 71 (71)/29 (29)
Median KPS score (range) 70 (60–90)
Primary tumor
 Carcinoma of the stomach 30 (30)
 Carcinoma of the colorectum 41 (41)
 Pseudomyxoma peritonei 13 (13)
 Carcinoma of ovary and primary peritoneum 16 (16)
Histopathology
 Adenocarcinoma, poorly/intermediately differentiated 44 (44)
 Undifferentiated carcinoma 3 (3)
 Myxoadenocarcinoma and signet-ring cell carcinoma 26 (26)
 Serous adencarcinoma 14 (14)
 Pseudomyxoma peritonei 13 (13)
Neoadjuvant chemotherapy
 Yes/no 47 (47)/53 (53)
PC timinga
 Synchronous/metachronous 80 (80)/20 (20)
PCI scoresa
 ≤20/>20 44 (44)/56 (56)
 Median PCI scores (range) 22 (3–39)
Ascites at surgeryb
 ≤1000 mL/>1000 mL 63 (63)/37 (37)
Surgical procedures-organ resection
 Partial/total gastrectomy 24 (24)
 Resection of jejunum 4 (4)
 Resection of ileum 12 (12)
 Resection of ileocecus 32 (32)
 Ascending colectomy 27 (27)
 Transverse colectomy 32 (32)
 Descending colectomy 12 (12)
 Sigmoidectomy 16 (16)
 Rectectomy 29 (29)
 Resection ovarian/fallopian tube 29 (29)
 Hysterectomy 15 (15)
 Partial hepatectomy 2 (2)
 Splenectomy 11 (11)
 Cholecystectomy 11 (11)
Number of organ resecteda,c
 1–3 resections 59 (67.1)
 4–7 resections 23 (26.1)
 8–12 resections 6 (6.8)
Peritonectomya
 Greater/lesser omentum 92 (92)
 Left diaphragmatic copula 15 (15)
 Right diaphragmatic copula 38 (38)
 Right colon gutter 41 (41)
 Left colon gutter 42 (42)
 Liver round ligament/sickle ligament 53 (53)
 Douglas/rectovesical pouch 49 (49)
 Anterior wall peritoneum 40 (40)
 Pelvic peritoneum 58 (58)
 Mesenteric fulguration 66 (66)
Peritoneal resection areaa
 1–3 resections 44 (44)
 4–6 resections 16 (16)
 7–12 resections 40 (40)
CC scoresa
 0 30 (30)
 1 32 (32)
 2–3 38 (38)
Number of anastomosisa
 None or ostomy only 25 (25)
 =1/>1 35 (35)/40 (40)
Postoperative chemotherapy moded
 SC/SC + IP 31 (38.3)/50 (61.7)
Postoperative chemotherapy cycles
 <6/≥6 49 (49)/51 (51)
Median postoperative chemotherapy cycles (range) 6 (1–12)
 Median postoperative SC/IP + SC cycles (range)d 5 (1–12)/6 (1–12)
Median duration of ICU (hours) (range) 22 (11–94)
Median duration of hospitalization (days) (range) 20 (10–76)
 Median follow-up (months) (range) 19.7 (7.5–89.2)
  1. aAccording to the first surgery
  2. bFive patients each underwent two operations
  3. c12 patients without organ resection
  4. d19 patients without any postoperative chemotherapy
  5. PC peritoneal carcinomatosis, KPS Karnofsky performance score, PCI peritoneal cancer index, CC completeness of cytoreduction, SC systemic chemotherapy, IP intraperitoneal chemotherapy, ICU intensive care unit